Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Rite Aid Corporation    RAD

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

Rite Aid February Same-Store Sales Rose 3.1%; Up 3% In 4Q

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/08/2012 | 03:07pm CET

Rite Aid Corp.'s (>> Rite Aid Corporation) same-store sales rose 3.1% in February, marking the 11th straight month of growth for the drug store chain.

The No. 3 U.S. drug store chain behind Walgreen Co. (>> Walgreen Company) and CVS Caremark Corp. (>> CVS Caremark Corporation) reported same-store sales growth in all but one month last year -- March had a 0.1% drop -- with a boost from the rollout of a loyalty program and store renovations that expanded clinical pharmacy services and health and wellness products choices.

During February, same-store sales were up 1.9% in the front of the store. Pharmacy same-store sales increased 3.7%, despite a negative impact of 2.42 percentage points from generic drug introductions. Same-store prescription counts were up 2.2%.

For the fiscal fourth quarter ended March 3, same-store sales improved 3%, including growth of 1.6% in the front of the store and 3.8% in the pharmacy section.

Total February drug store sales rose 2.3% to $2.55 billion. Prescription sales accounted for 68.3% of drugstore sales.

For the quarter, total drug store sales rose 2.5% to $7.12 billion.

Rite-Aid, which has about 4,667 stores, has posted losses since its 2007 acquisition of the Brooks Eckerd Pharmacy chain stores that saddled it with debt just before consumers slashed spending.

The company in December reported that its fiscal third-quarter loss narrowed as same-store sales grew for a fourth consecutive quarter and interest expense and lease termination and write-down charges declined.

Shares were up 1.2% at $1.71 in recent premarket trading. Through Wednesday's close, the stock is up by slightly more than a third this year.

 
   -By Tess Stynes, Dow Jones Newswires; 212-416-2481; Tess.Stynes@dowjones.com 
 

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on RITE AID CORPORATION
02/24 RITE AID : Expands Naloxone Dispensing Program in Six Additional States
02/23 RITE AID : Metro Council to take up Rite Aid tax remittance, River Center contra..
02/20 RITE AID : KIDCENTS Chase Home receives $5,000 grant
02/20 RITE AID : 48-year-old Pharmacist gets indicted for thieving drugs and falsifyin..
02/20 RITE AID : Three arrested after car chase
02/17 RITE AID : At least once a year
02/15 RITE AID : Expands Naloxone Dispensing Program in Six Additional States
02/15 RITE AID : Stroudsburg Rite-Aid project moves forward
02/14 RITE AID : Chase Home Receives $5,000 Grant
02/14 RITE AID : robber strikes again
More news
Sector news : Retail - Drugs without Grocery
02/16DJRetail CEOs Meet With Trump Over Border Tax Concerns -- Update
02/15DJRetail CEOs Meet With Trump Over Border Tax Concerns
02/14DJEXPRESS SCRIPTS : Revenue Falls
02/14 Exclusive - Trump to meet with retail CEOs on taxes, infrastructure
02/09DJCVS HEALTH : Profit Rises, Helped by Pharmacy Strength -- Update
More sector news : Retail - Drugs without Grocery
News from SeekingAlpha
02/24 Rite Aid Investors Should Take A Hard Look The Walgreens Merger Valuation Bef..
02/19 Tracking David Einhorn's Portfolio - Q4 2016 Update
02/17 Micron Technology Is A Cheap Stock - Cramer's Lightning Round (2/16/17)
02/15 Greenlight Capital ups stake in Rite Aid
02/15 Top Merger Stocks Held By Fund Managers (Mid-Q1 2017 Edition)
Advertisement
Financials ($)
Sales 2017 32 563 M
EBIT 2017 540 M
Net income 2017 62,4 M
Debt 2017 6 906 M
Yield 2017 -
P/E ratio 2017 92,56
P/E ratio 2018 52,23
EV / Sales 2017 0,41x
EV / Sales 2018 0,39x
Capitalization 6 283 M
More Financials
Chart RITE AID CORPORATION
Duration : Period :
Rite Aid Corporation Technical Analysis Chart | RAD | US7677541044 | 4-Traders
Full-screen chart
Technical analysis trends RITE AID CORPORATION
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 7
Average target price 6,92 $
Spread / Average Target 16%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
John T. Standley Chairman & Chief Executive Officer
Kenneth A. Martindale President & CEO-Rite Aid Stores
Bryan B. Everett Executive Vice President-Store Operations
Darren W. Karst Chief Financial & Administrative Officer, SEVP
Steve Rempel Chief Information Officer & Senior Vice President
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
RITE AID CORPORATION-28.28%6 283
RAIA DROGASIL SA-0.96%6 319
AIN HOLDINGS INC4.39%2 297
ADCOCK INGRAM HOLDINGS..20.81%790
ORIOLA KD OYJ-8.12%754
AUSTRALIAN PHARMACEUTI..-8.01%710
More Results